A few days after the late-stage win, Lilly CEO David Ricks told Fox Business that while the study was primarily in diabetes, the pharmas first drug application for orforglipron will be for chronic weight management later this year
Novo Nordisk are leaning heavily into their oral formulation of Semaglutide, Rybelsus , (Oral formulations face their own unique challenges due to the requirement to avoid extensive degradation of the drug by the digestive system), which although shows less weight loss compared to other competitors, has the convenience of not requiring injections
Topical application is the preferred route for cosmetic-adjacent skin research because it delivers the peptide directly to the target tissue while avoiding systemic exposure
The acute effects of four protein meals on insulin, glucose, appetite, and energy intake in lean men
Opportunities for Functional Beverage Brands The rising demand for GLP-1 drugs provides functional beverage brands with an opportunity to innovate for and capture this growing market segment
[148] have highlighted the neuropsychiatric dimensions of GLP-1 RAs, including their potential relevance for relapse vulnerability and cognitive-affective regulation after pharmacotherapy discontinuation